Clarithromycin Recruiting Phase 3 Trials for Atypical; Mycobacterium, Pulmonary, Tuberculous Treatment

IndicationsStatusPurposePhase
RecruitingTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT01298336Treatment of Mycobacterium Xenopi Pulmonary Infection